We have located links that may give you full text access.
IN VITRO
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Propionyl L-carnitine improvement of hypertrophied rat heart function is associated with an increase in cardiac efficiency.
European Journal of Pharmacology 1995 November 15
Although propionyl L-carnitine improves contractile function of hypertrophied rat hearts, the mechanism(s) by which it does this are not known. One postulated mechanism is that propionyl L-carnitine reverses the alterations in energy metabolism that occur secondary to the carnitine deficiency seen in hypertrophied myocardium. This study determined the effects of chronic propionyl L-carnitine administration on myocardial carnitine content and energy metabolism in hypertrophic hearts from male Wistar Kyoto rats. Pressure-overload hypertrophy was produced by constriction of the abdominal aorta in juvenile rats. Propionyl L-carnitine was administered to the rats via the drinking water for an 8 week period (60 mg.kg(-1).day-1). Myocardial function and metabolic analysis was determined in isolated working hearts obtained from aortic-banded and sham-operated (control) animals at the end of the 8 week study period. Carnitine content was significantly decreased in hypertrophied hearts compared to control hearts, but was normalized by propionyl L-carnitine treatment. Propionyl L-carnitine treatment also prevented the decrease in cardiac work that occurred in hypertrophied hearts compared to control hearts. The primary change in energy substrate use in hypertrophied hearts was a decrease in fatty acid oxidation rates. Glucose and lactate oxidation were similar in control and hypertrophied hearts. While glycolytic rates were slightly higher at moderate workloads, this was not seen at high workloads. Surprisingly, propionyl L-carnitine treatment did not reverse the depression of fatty acid oxidation seen in hypertrophied rat hearts. In fact, a further significant decrease in fatty acid oxidation occurred, such that the contribution of fatty acid oxidation to ATP production decreased from 35 to 26%. Since propionyl L-carnitine treatment increased cardiac work in hypertrophied hearts despite an overall decrease in ATP production rates, an increase in cardiac efficiency was seen. In treated vs. untreated hypertrophied hearts efficiency (cardiac work/ATP produced) increased from 0.23 to 0.40 ml.mm Hg.mumol ATP-1.g dry weight at high workloads. These data suggest that the beneficial effect of propionyl L-carnitine on mechanical function in the hypertrophied heart does not result from a normalization of fatty acid oxidation, but rather from an increase in the efficiency of translating ATP production into cardiac work.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app